Development of potent dual BET/HDAC inhibitors via pharmacophore merging and structure-guided optimization
N. Bauer, D.-I. Balourdas, J. R. Schneider…·A. C. Joerger
This study develops potent dual BET/HDAC inhibitors through pharmacophore merging and structure-guided optimization, showing improved potency and efficacy in cancer cell models.